Product Information
PERINDOPRIL ERBUMINE 4 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5147 per EA under NDC 65862028701. Its NADAC has been published 653 times since Nov 28, 2013.
Strength
4 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862028701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PERINDOPRIL ERBUMINEApproval Type
Generic (ANDA)
FDA Application
ANDA079070On Market Since
11/10/2009
Pharmacological Classes
Price Statistics
The NADAC for PERINDOPRIL ERBUMINE 4 MG TAB has been published 653 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5147 per EA |
|---|---|
| All-time high | $0.5877 (May 13, 2015) |
| All-time low | $0.3759 (Jun 20, 2018) |
| 52-week high | $0.5454 |
| 52-week low | $0.4830 |
| Median price | $0.4768 |
| Average price | $0.4718 |
| Largest weekly change | +26.9% (Nov 23, 2016) |
| Weeks tracked | 653 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Perindopril Erbumine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PERINDOPRIL ERBUMINE 4 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PERINDOPRIL ERBUMINE 4 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.5147 per EA (NDC 65862028701), effective Jun 24, 2026.
How has the price of PERINDOPRIL ERBUMINE 4 MG TAB changed over time?
Over the history we have for it, the NADAC for PERINDOPRIL ERBUMINE 4 MG TAB has held within roughly two percent of its current level. It has been tracked across 653 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PERINDOPRIL ERBUMINE 4 MG TAB?
Since Nov 28, 2013, the NADAC for PERINDOPRIL ERBUMINE 4 MG TAB has ranged from a low of $0.3759 (Jun 20, 2018) to a high of $0.5877 (May 13, 2015), with a median of $0.4768 per EA.
Are there cheaper alternatives to PERINDOPRIL ERBUMINE 4 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PERINDOPRIL ERBUMINE 4 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures PERINDOPRIL ERBUMINE 4 MG TAB?
PERINDOPRIL ERBUMINE 4 MG TAB (NDC 65862028701) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification